Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROMFENAC vs BROMOCRIPTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BROMFENAC vs BROMOCRIPTINE: Safety Overview

Metric BROMFENAC BROMOCRIPTINE
Total FAERS Reports 1,185 864
Deaths Reported 1 75
Death Rate 0.1% 8.7%
Hospitalizations 35 308
Average Patient Age 70.5 yrs 41.4 yrs
% Female Patients 66.2% 57.5%
FDA Approval Date Apr 5, 2013 Approved Prior to Jan 1, 1982
Manufacturer Alembic Pharmaceuticals Limited Zydus Pharmaceuticals USA Inc.
Route OPHTHALMIC ORAL
Marketing Status Discontinued Prescription